World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12615001171505
Date of registration: 02/11/2015
Prospective Registration: No
Primary sponsor: Thrive Networks
Public title: Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates with jaundice in Myanmar, comparing pre- and post-intervention rates
Scientific title: Evaluation of a simple phototherapy-related intervention to reduce exchange transfusion rates, comparing pre- and post-intervention rates in two hospitals treating inborn neonates with jaundice and two hospitals treating outborn neonates with jaundice
Date of first enrolment: 01/01/2011
Target sample size: 3000
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12615001171505.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Non-randomised trial; Masking: Open (masking not used);Assignment: Other;Type of endpoint: Efficacy;  
Phase:  Not Applicable
Countries of recruitment
Myanmar
Contacts
Name: Dr Gaston Arnolda   
Address:  Adjunct Senior Lecturer, Department of Public Health and Community Medicine, University of New South Wales C/o 15 Trouton St Balmain, NSW, 2041 Australia
Telephone: +61405720550
Email: gaston.arnolda@gmail.com
Affiliation: 
Name: Dr Gaston Arnolda   
Address:  Adjunct Senior Lecturer Department of Public Health and Community Medicine, University of New South Wales C/o 15 Trouton St Balmain, NSW, 2041 Australia
Telephone: +61405720550
Email: gaston.arnolda@gmail.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: All infants admitted to the neonatal care unit for treatment of neonatal jaundice, in four Myanmar hospitals, two exclusively treating inborn neonates and two exclusively treating outborn neonates
Exclusion criteria: None

Age minimum: Days
Age maximum: 28 Days
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Exchange transfusion for neonatal jaundice;
Exchange transfusion for neonatal jaundice
Reproductive Health and Childbirth - Complications of newborn
Intervention(s)
1) Provision of high intensity phototherapy and a photo radiometer;
2) Promulgation of standard guidelines for phototherapy and exchange transfusion, as used by the lead Myanmar hospital responsible for neonatal care policy. American Academy of Pediatrics 2004 guidelines for infants born at 35 weeks gestation and above specify Total Serum Bilirubin thresholds for commencement of intensive (>=30 W/cm2 per nm at 430-490 nm) and standard (<30 W/cm2 per nm at 430-490 nm) phototherapy and Exchange transfusion, by infant age in hours and risk factors (including gestational age-group). The UK National Institute of Clinical Excellence 2010 guidelines (used for infants born <35 weeks gestation by the Myanmar lead hospital for neonatal care) provide thresholds for phototherapy and Exchange Transfusion by gestational week at birth, and age in hours. Hospitals were given coloured graphs reproduced from the American Academy of Pediatrics guideline to affix to nursery walls, and MS Excel spreadsheets containing the NICE thresholds. Adherence to the guidelines was not externally monitored during the intervention period.
3) Half day training in use of the equipment and guidelines by an Italian Neonatologist. Training was provided in two cities, Yangon and Mandalay, on separate dates, each catering to key staff from two hospitals; 19 staff attended at one location and 21 at the other. Training was by lecture format, with discussion of the guidelines and exercises to demonstrate use of the guidelines, followed by hands-on practice in use of the equipment.
Primary Outcome(s)
Exchange transfusion rate, calculated as a proportion of infants admitted for treatment of jaundice, assessed using data recorded in the exchange transfusion registers and neonatal care unit admission registers, respectively.[12 months pre- and post-intervention]
Secondary Outcome(s)
None[None]
Secondary ID(s)
None
Source(s) of Monetary Support
Archdiocese of Trento
Eric Hemel & Barbara Morgen
Amici della Neonatologia, Trentina
Secondary Sponsor(s)
Not Applicable
Ethics review
Status: Approved
Approval date:
Contact:
Ethical Committee on Medical Research Involving Human Subjects, Department of Health, Myanmar
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history